Web Analytics

3 Latest Announced Rounds

$1,402.84M Raised in 45 Funding Rounds in the past 7 Days - View All

Funding Round Profile

ParcelBio

start up
United States - San Francisco, California
  • 08/05/2026
  • Seed
  • $13,000,000

ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.


Related People

David WeinbergCo Founder

David Weinberg United States - San Francisco Bay Area

N/A